Share Search
Visit the Share Search
You are here:
Hikma Pharmaceuticals Accounts Summary
| Date of Accounts | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
| Revenue | 3,349.00 | 3,127.00 | 2,875.00 | 2,517.00 | 2,553.00 |
| Operating Profit / Loss | 542.00 | 612.00 | 367.00 | 282.00 | 582.00 |
| Net Interest | -24.00 | -159.00 | -88.00 | -52.00 | -39.00 |
| Pre Tax Profit | 519.00 | 455.00 | 281.00 | 233.00 | 544.00 |
| Post Tax Profit | 407.00 | 362.00 | 192.00 | 191.00 | 420.00 |
| Profit for the Period | 407.00 | 362.00 | 192.00 | 191.00 | 420.00 |
| Equity Holders of Parent Company | 402.00 | 359.00 | -302.00 | 188.00 | 421.00 |
| Minority Interests | 5.00 | 3.00 | -1.00 | 3.00 | -1.00 |
| Continuing EPS | |||||
| Earnings per Share (Basic) | 182.00 USX | 162.00 USX | 86.00 USX | 84.00 USX | 182.30 USX |
| Earnings per Share (Diluted) | 181.00 USX | 161.00 USX | 85.00 USX | 84.00 USX | 180.70 USX |
| Earnings per Share (Adjusted) | 228.00 USX | 224.00 USX | 223.00 USX | 181.00 USX | 194.80 USX |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | 182.00 USX | 162.00 USX | 86.00 USX | 84.00 USX | 182.30 USX |
| Earnings per Share (Diluted) | 181.00 USX | 161.00 USX | 85.00 USX | 84.00 USX | 180.70 USX |
| Earnings per Share (Adjusted) | 228.00 USX | 224.00 USX | 223.00 USX | 181.00 USX | 194.80 USX |
| Dividend per Share | 0.84 USD | 0.80 USD | 0.72 USD | 0.56 USD | 0.54 USD |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
| Non-Current Assets | |||||
| Intangible Assets | 1,170.00 | 1,156.00 | 1,100.00 | 1,124.00 | 892.00 |
| Property, Plant and Equipment | 1,448.00 | 1,326.00 | 1,141.00 | 1,081.00 | 1,146.00 |
| Investments | 11.00 | 11.00 | 10.00 | 10.00 | 10.00 |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Other Financial Assets | n/a | n/a | 103.00 | 65.00 | 47.00 |
| Other Non-Current Assets | 399.00 | 377.00 | 226.00 | 192.00 | 183.00 |
| Total Non-Current Assets | 3,028.00 | 2,870.00 | 2,580.00 | 2,472.00 | 2,278.00 |
| Current Assets | |||||
| Inventories | 1,106.00 | 986.00 | 891.00 | 776.00 | 695.00 |
| Trade and Other Receivables | 1,061.00 | 949.00 | 824.00 | 841.00 | 876.00 |
| Cash at Bank and in Hand | 217.00 | 188.00 | 205.00 | 270.00 | 426.00 |
| Current Asset Investments | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 259.00 | 140.00 | 169.00 | 112.00 | 97.00 |
| Total Current Assets | 2,643.00 | 2,263.00 | 2,089.00 | 1,999.00 | 2,094.00 |
| Other Assets | n/a | n/a | 11.00 | n/a | n/a |
| Total Assets | 5,671.00 | 5,133.00 | 4,680.00 | 4,471.00 | 4,372.00 |
| Current Liabilities | |||||
| Borrowings | 114.00 | 653.00 | 161.00 | 148.00 | 121.00 |
| Other Current Liabilities | 1,339.00 | 1,325.00 | 1,178.00 | 929.00 | 895.00 |
| Total Current Liabilities | 1,453.00 | 1,978.00 | 1,339.00 | 1,077.00 | 1,016.00 |
| Net Current Assets | n/a | n/a | n/a | n/a | n/a |
| Non-Current Liabilities | |||||
| Borrowings | 1,490.00 | 653.00 | 1,030.00 | 1,135.00 | 725.00 |
| Provisions | 56.00 | 54.00 | 32.00 | 19.00 | 24.00 |
| Other Non-Current Liabilities | 66.00 | 127.00 | 70.00 | 92.00 | 140.00 |
| Total Non-Current Liabilities | 1,612.00 | 834.00 | 1,132.00 | 1,246.00 | 889.00 |
| Net Assets | 2,606.00 | 2,321.00 | 2,209.00 | 2,148.00 | 2,467.00 |
| Capital and Reserves | |||||
| Share Capital | 40.00 | 40.00 | 40.00 | 40.00 | 42.00 |
| Share Premium Account | 282.00 | 282.00 | 282.00 | 282.00 | 282.00 |
| Other Reserves | -285.00 | -374.00 | -282.00 | -279.00 | -60.00 |
| Retained Earnings | 2,556.00 | 2,362.00 | 2,158.00 | 2,092.00 | 2,189.00 |
| Shareholders Funds | 2,593.00 | 2,310.00 | 2,198.00 | 2,135.00 | 2,453.00 |
| Minority Interests / Other Equity | 13.00 | 11.00 | 11.00 | 13.00 | 14.00 |
| Total Equity | 2,606.00 | 2,321.00 | 2,209.00 | 2,148.00 | 2,467.00 |
| 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 | |
| Operating Margin | 16.18% | 19.57% | 12.77% | 11.20% | 22.80% |
| Return on Capital Employed | 17.54% | 24.32% | 15.82% | 12.25% | 23.84% |
| Dividend Cover | 2.71 | 2.80 | 3.10 | 3.23 | 3.61 |
| Dividend Yield | 4.00 | 3.00 | 3.00 | 2.70 | 1.80 |
| PE Ratio | 9.20 | 12.00 | 10.80 | 11.60 | 15.40 |
| PEG | n/a | n/a | n/a | n/a | 1.90 |
| Dividend per Share Growth | n/a% | -4.76% | -10.00% | -22.22% | -3.57% |
| Net Asset Value per Share | 6.47 USD | 5.25 USD | 5.00 USD | 4.62 USD | 7.10 USD |